| Application no. and date | 02774103.2 (espacenet) (Federated) (European Patent Register), 20020509 | | Patent/reg. no. and date | DK/EP 1401498, 20110831 | | Publication date | 20040331 | | Priority no. and date | US 294392 P, 20010530 | | EP pub. no. and date |
EP 1401498 20040331 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US | | Applicant ref. no. | P49086DK01 | | Inventor | SHELTON, David, L., 5845 Clover Drive
Oakland, CA 94618, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) | | Title | Anti-NGF-antistoffer til behandlingen af forskellige sygdomme | | Int. application no. | US2002015284 | | Int. publication no. | WO2002096458 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
